Part I of the Alliance for Health Policy’s 2020 Signature Series focused on disruptors and transformers in health care. During this Summit, expert panelists explored the short and long-term impacts of the ongoing COVID-19 pandemic and its potential to significantly transform our health care system.
The Signature Series events are traditionally held in-person in the Nation’s Capital. This year, we turned the Summit into a virtual event to provide even more audiences the opportunity to participate in these cutting-edge discussions.
This week-long event sought to showcase innovations and meaningful conversations through live panels, keynote presentations, online dialogues, and a shared community narrative in the digital world. Speakers discussed disruptive and transformative themes and trends as they relate to COVID-19—new business and care delivery models, technological and scientific advances, health equity, early lessons learned—and what they mean for patients and policy.
With our move to a virtual platform, we strive to stay true to the Alliance’s role as a convener and community creator. We welcomed audience members to participate in the discussion using the hashtag #AHPSummit20 across Twitter and Facebook.
Schedule of Events
Tuesday, July 21
- Panel #1: The Invisible Backbone – Strengthening Supply Chain and Public Health Infrastructure | 12 p.m. EST | Learn more »
- Keynote #1: Perspectives on Health Equity with Dr. Rashawn Ray and Licy Do Canto | 2 p.m. EST | Learn more »
Wednesday, July 22
- Panel #2: Care Delivery Transformation – Integrating Telehealth and Home-Based Care | 12 p.m. EST | Learn more »
- Executive Insights Interview: A conversation with Jenny Bryant of PhRMA (sponsored event) | 2 p.m. EST | Learn more »
Thursday, July 23
- Panel #3: Using Data to Disrupt the Spread of COVID-19 and Prevent Future Pandemics | 12 p.m. EST | Learn more »
- Keynote #2: A Conversation on Innovative Research Approaches to Advance Our Understanding and Treatment of COVID-19 | 2 p.m. EST | Learn more »
Friday, July 24
- Conversations on Twitter throughout the day to survey the audience for key takeaways and reflections from the week.
- Jennifer B. Alton, MPP, Senior Strategy and Policy Advisor, Coalition to Stop Flu
- Christopher P. Austin, M.D., Director, National Center for Advancing Translational Sciences, National Institutes of Health
- Jenny Bryant, MBA, Executive Vice President, Policy and Research, PhRMA
- Ravi Chawla, MBA, M.S., Vice President of Informatics, Independence Blue Cross
- Anita Cicero, J.D., Deputy Director, Center for Health Security, Johns Hopkins Bloomberg School of Public Health (moderator)
- Sarah J. Dash, MPH, President and Chief Executive Officer, Alliance for Health Policy (moderator)
- Licy Do Canto, Executive Vice President, Managing Director, BCW Public Affairs and Crisis (moderator)
- Nancy Green, President and Founder, The SAA Group, LLC
- Nicolette Louissaint, Ph.D., Executive Director, Healthcare Ready
- Kenneth Mandl, M.D., MPH, Director of Computational Health Informatics, Boston Children’s Hospital
- Deven McGraw, J.D., Cofounder and Chief Regulatory Officer, Ciitizen
- Geoffrey Nudd, MBA, CEO of ClearCare, a WellSky Company
- Anand Parekh, M.D., MPH, Chief Medical Advisor, Bipartisan Policy Center (moderator)
- Jennifer Rakeman, Ph.D., Assistant Commissioner and Laboratory Director, New York City Department of Health and Mental Hygiene
- Rashawn Ray, Ph.D., M.A., David M. Rubenstein Fellow, Governance Studies, Brookings Institution
- Michael Reese Wittke, MPA, Senior Director, Public Policy and Advocacy, National Alliance for Caregiving
- Robert Saunders, Ph.D., Research Director, Payment and Delivery System Reform, Duke-Margolis Center for Health Policy (moderator)
- Dorothy Siemon, J.D., Senior Vice President, Office of Policy Development and Integration, AARP
- Kaakpema “KP” Yelpaala, MPH, CEO and Founder, access.mobile International
Thank you to our 2020 Virtual Summit sponsors!
Over the past 100 days of the pandemic, the U.S. health care delivery system was required to quickly incorporate more digital technologies in order to remotely care for patients and minimize their exposure to the novel coronavirus. The Coronavirus Aid, Relief, and Economic Security (CARES) Act earmarked $200 million in funding to assist health care providers in delivering connected care services in their homes […]...
Pandemic responses require efficient flow of materials (like vaccines, supplies, and equipment), information, and workforce across the entire system. The COVID-19 pandemic exposed deep gaps and flaws in the United States public health infrastructure and supply chain—leading to shortages and disruptions throughout all levels of care and prevention. In order to successfully stop the spread […]...
Event Description This keynote discussion explored structural conditions that have lead to health disparities before COVID and during the current pandemic as well as policy levers to address these inequities. Speakers Rashawn Ray, Ph.D., M.A., David M. Rubenstein Fellow, Governance Studies, Brookings Institution Licy Do Canto, Executive Vice President, Managing Director, BCW Public Affairs and Crisis (moderator) Biographies […]...
This panel explored the role of data sharing, interoperability, and health IT in tracking and stemming the spread of COVID-19. Panelists: Ravi Chawla, MBA, M.S., Vice President of Informatics, Independence Blue Cross Kenneth Mandl, M.D., MPH, Director of Computational Health Informatics, Boston Children’s Hospital Deven McGraw, J.D., MPH, LLM, Cofounder and Chief Regulatory Officer, Ciitizen […]...
Event Description On July 14 2020, Chris P. Austin, M.D., director of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) joined us for a conversation about leveraging data analytics to advance our understanding and treatment of COVID-19. Dr. Austin and his team at the NIH recently launched the […]...
*This was a sponsored event. Speaker Jenny Bryant, MBA, serves as executive vice president of policy and research for the Pharmaceutical Research and Manufacturers of America (PhRMA). PhRMA advocates for public policies that encourage the discovery of life-saving and life-enhancing new medicines for patients by biopharmaceutical research companies. Ms. Bryant leads PhRMA’s policy and research […]...